Skip to main content
. 2004 Jul 19;2004(3):CD003269. doi: 10.1002/14651858.CD003269.pub2

Laitinen 1979.

Methods Crossover design; 1st phase 3 weeks, 2nd phase 2 weeks.
Participants  
Interventions Ipratropium bromide 80µg and salbutamol 400µg; both interventions q.i.d.
Outcomes  
Notes This comparison not analysed, so details not extracted.
Risk of bias
Bias Authors' judgement Support for judgement
Allocation concealment (selection bias) Unclear risk Information not available (Cochrane Grade B)